Arm’s run in 2026 has been one of the sharpest re-ratings in large-cap tech. Shares of Arm Holdings (NASDAQ:ARM | ARM Price Prediction) trade at $271.49 as of July 20, 2026, up 144.43% year to date on the back of a data center royalty explosion and the launch of Arm’s first production silicon.
Our 24/7 Wall St. price target for Arm is $301.87, implying 11.19% upside over the next twelve months. The action is buy, with a confidence level of 90%.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $271.49 |
| 24/7 Wall St. Price Target | $301.87 |
| Upside | 11.19% |
| Recommendation | BUY |
| Confidence Level | 90% |
A Volatile Path to a 144% YTD Gain
Arm bottomed near $105.78 in January before ripping to a June high of $396.34 and pulling back to today’s level. The stock is off 17.38% over the past week and 36.21% over the past month, sitting 33% below its 52-week high of $452.70.
In Q4 FY2026, Arm posted revenue of $1.49 billion, up 20.06% year over year, with non-GAAP EPS of $0.60 beating the $0.5793 consensus. License revenue jumped 29% and data center royalty revenue more than doubled year over year. Full-year FY2026 revenue reached $4.92 billion, up 22.79%, a third straight year above 20% growth.
Why Bulls See Arm Following Nvidia’s Playbook
The bull case rests on more than $2 billion in customer demand for the Arm AGI CPU across FY27 and FY28. Meta is the lead partner on a multi-generation roadmap targeting 3+ billion users.
Google is replacing x86 host processors with custom Arm-based Axion CPUs in next-gen TPUs. NVIDIA announced Vera, its next Arm-based CPU. Microsoft is expanding Cobalt across Azure. Arm claims roughly 50% CPU compute share among top hyperscalers.
Management is tracking toward a $15 billion silicon business forecast against a data center CPU market that could exceed $100 billion by 2030. If the AGI CPU ramp materializes, the bull-case scenario points to $434.24 within twelve months, a 59.95% return.
What Could Go Wrong
Valuation is the biggest hurdle. Arm trades at a trailing P/E of 311 and a forward P/E of 122. Non-GAAP operating margin compressed from 52.8% to 49.1% as R&D spending jumped 43% to $1.911 billion. Bulls note this reflects deliberate investment in AGI CPU engineering that should scale as royalties ramp.
The Qualcomm/Nuvia trial expected in Q4 calendar 2026, SoftBank’s controlling stake, and export-control risk all weigh. The bear scenario points to $238.31, a 12.22% drawdown.
How Arm Compares to Nvidia and Broadcom
NVIDIA (NASDAQ:NVDA) trades at $202.81 with a YTD gain of just 8.88%, versus Arm’s 144%. Arm trails Nvidia in scale, yet its royalty model captures a slice of every hyperscaler’s custom silicon roadmap, including Nvidia’s own Vera CPU. That relationship makes our target look conservative if Arm’s per-chip take rate expands.
Broadcom (NASDAQ:AVGO) is the sharper comp on custom AI silicon economics. It posted Q2 FY2026 AI semiconductor revenue of $10.8 billion, up 143% YoY, and guided Q3 AI revenue to $16 billion.
Broadcom already runs a hyperscaler custom silicon business at scale, exactly where Arm is heading. Arm’s $271 price implies investors are willing to pay for the same trajectory earlier, making our 11% upside target measured rather than aggressive.
What Would Confirm or Break the Thesis
The 24/7 Wall St. price target of $301.87 with 90% confidence backs a buy. The tipping factor is the AGI CPU demand book: $2 billion locked in across FY27-FY28 represents concrete, contracted demand.
The setup looks constructive if Q1 FY27 lands inside guidance and data center royalty growth stays north of 50%. The thesis weakens if operating margins slip below 45% or the Qualcomm/Nuvia trial produces a materially adverse ruling.
Extending the 24/7 Wall St. price target model forward and blending base and bull-case trajectories, here is where Arm could trade if the AGI CPU roadmap executes.
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $301.87 |
| 2027 | $335 |
| 2028 | $360 |
| 2029 | $378 |
| 2030 | $395.91 |
These projections assume Arm executes on the $15 billion silicon business forecast and holds hyperscaler CPU share near 50%. Significant upside is possible if agentic AI CPU demand outpaces the 4x-per-gigawatt baseline, and downside if licensing disputes or export controls disrupt the royalty ramp.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks